Holen Sie sich die Stockscreener-App
115.20
4.93%
5.41
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$109.79
Offen:
$110.8
24-Stunden-Volumen:
670.06K
Relative Volume:
1.18
Marktkapitalisierung:
$5.09B
Einnahmen:
$3.03B
Nettoeinkommen (Verlust:
$237.44M
KGV:
22.90
EPS:
5.03
Netto-Cashflow:
$450.04M
1W Leistung:
+1.52%
1M Leistung:
-2.63%
6M Leistung:
-36.27%
1J Leistung:
-48.25%
1-Tages-Spanne:
$108.90
$115.22
1-Wochen-Bereich:
$108.90
$115.22
52-Wochen-Spanne:
$108.90
$249.91
Teleflex Incorporated Stock (TFX) Company Profile
Firmenname
Teleflex Incorporated
Sektor
Telefon
610-225-6800
Adresse
550 E SWEDESFORD RD, WAYNE, PA
Vergleichen Sie TFX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
115.20 | 5.01B | 3.03B | 237.44M | 450.04M | 5.03 |
|
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-02-28 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-02-27 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-07-01 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-21 | Herabstufung | Needham | Buy → Hold |
| 2023-05-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-04-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-10-26 | Eingeleitet | Mizuho | Neutral |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-29 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-09-07 | Fortgesetzt | Raymond James | Outperform |
| 2021-07-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-01-06 | Bestätigt | Needham | Buy |
| 2020-11-02 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Wells Fargo | Outperform |
| 2019-04-24 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-02-22 | Bestätigt | Needham | Strong Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-09-10 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-08-03 | Bestätigt | Needham | Buy |
| 2018-05-14 | Bestätigt | Needham | Buy |
| 2018-05-04 | Bestätigt | Needham | Buy |
| 2018-04-04 | Eingeleitet | Goldman | Neutral |
| 2017-11-10 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-11-03 | Bestätigt | Needham | Buy |
| 2017-09-08 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2017-09-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-06 | Bestätigt | Needham | Buy |
| 2017-03-07 | Eingeleitet | Needham | Buy |
| 2017-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2016-07-12 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Teleflex Incorporated Aktie (TFX) Neueste Nachrichten
Is Teleflex Incorporated a good long term investmentExplosive earnings growth - jammulinksnews.com
What drives Teleflex Incorporated stock priceDynamic investment growth - jammulinksnews.com
Teleflex Incorporated Stock Analysis and ForecastSpectacular growth rates - jammulinksnews.com
What analysts say about Teleflex Incorporated stockOutstanding yields - Autocar Professional
Teleflex stock hits 52-week low at 110.83 USD - Investing.com
Teleflex to Announce Q2 2025 Results: Join the Live Call July 31 - MSN
Vascular Access Devices Company Evaluation Report 2025 | Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation - Yahoo Finance
Teleflex Announces Second Quarter 2025 Earnings Conference Call Information - GlobeNewswire
Teleflex Sets Q2 2025 Earnings Call Date: Key Financial Updates Coming July 31 - Stock Titan
Morgan Stanley Remains a Buy on Teleflex (TFX) - The Globe and Mail
Teleflex Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) - Benzinga
Teleflex stock price target lowered to $130 by RBC Capital - Investing.com Nigeria
Teleflex stock hits 52-week low at $115.77 By Investing.com - Investing.com India
Teleflex stock hits 52-week low at $115.77 - Investing.com
Teleflex Announces Leadership Transition as CFO Thomas E. Powell Retires - MSN
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
Markets | American Financial Group, Inc. - FinancialContent
Needham maintains Hold rating on Teleflex stock after Biotronik acquisition By Investing.com - Investing.com Nigeria
Teleflex Incorporated (NYSE:TFX) Not Lagging Market On Growth Or Pricing - simplywall.st
Should You Investigate Teleflex Incorporated (NYSE:TFX) At US$117? - 富途牛牛
Teleflex (TFX) Receives a Hold from Needham - The Globe and Mail
Teleflex Incorporated shares fall 1.19% intraday amid AI patent law concerns. - AInvest
Needham maintains Hold rating on Teleflex stock after Biotronik acquisition - Investing.com
Teleflex closes deal with BIOTRONIK - MSN
Teleflex signs MoU with Fortis Hospitals in India to create a UroLift Center of Education - Tribune India
Teleflex Acquires BIOTRONIK's Vascular Intervention Business, Stock Up - MSN
Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business - MSN
Teleflex's Strategic Move into Vascular Innovation: A Buy on Strong Catalysts Ahead - AInvest
Teleflex completes acquisition of Biotronik’s Vascular Intervention business - Vascular News
Teleflex Completes Acquisition of Biotronik's Vascular Intervention Business - MarketScreener
Teleflex Incorporated Enters into Amendment to its Third Amended and Restated Credit Agreement - MarketScreener
5 Insightful Analyst Questions From Teleflex’s Q1 Earnings Call - Yahoo Finance
Why Teleflex Incorporated (NYSE:TFX) Could Be Worth Watching - Yahoo Finance
Teleflex stock hits 52-week low at 118.66 USD - Investing.com
Teleflex stock hits 52-week low at 118.66 USD By Investing.com - Investing.com Nigeria
Finanzdaten der Teleflex Incorporated-Aktie (TFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):